ClinicalTrials.govpublic full text
Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors
sarcoma, metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor, recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803131
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.